SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-221436
Filing Date
2022-08-16
Accepted
2022-08-15 18:34:08
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-3 d393401ds3.htm S-3 352822
2 EX-1.2 d393401dex12.htm EX-1.2 198103
3 EX-4.4 d393401dex44.htm EX-4.4 286415
4 EX-5.1 d393401dex51.htm EX-5.1 23214
5 EX-5.2 d393401dex52.htm EX-5.2 12280
6 EX-23.1 d393401dex231.htm EX-23.1 1637
7 EX-FILING FEES d393401dexfilingfees.htm EX-FILING FEES 49716
8 GRAPHIC g393401g01n37.jpg GRAPHIC 64827
9 GRAPHIC g393401g01n54.jpg GRAPHIC 62533
10 GRAPHIC g393401g01n99.jpg GRAPHIC 66906
11 GRAPHIC g393401g0811125033797.jpg GRAPHIC 1728
12 GRAPHIC g393401g0811125033906.jpg GRAPHIC 2373
  Complete submission text file 0001193125-22-221436.txt   1199187
Mailing Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101
Business Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 (206) 737-0085
Icosavax, Inc. (Filer) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-266894 | Film No.: 221167831
SIC: 2836 Biological Products, (No Diagnostic Substances)